Capricor Therapeutics (0HTB) Share Forecast & Price Target
0HTB Analyst Ratings
0HTB Stock 12 Month Forecast
Average Price Target
EUR 24.21▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | H.C. Wainwright | ― | hold | ― | Reiterated | 10/06/26 | ||
| Boobalan Pachaiyappan | Roth MKM | EUR 6.28 | hold | ― | Reiterated | 10/06/26 | ||
| Catherine Novack | JonesTrading | ― | hold | ― | Reiterated | 09/27/26 | ||
| Madison Elsaadi | B. Riley Securities | EUR 4.48→EUR 18.83 | buy | ― | Upgraded | 09/14/26 | ||
| Edward Tenthoff | Piper Sandler | EUR 1.79→EUR 22.42 | buy | ― | Upgraded | 09/01/26 | ||
| Leland Gershell | Oppenheimer | EUR 48.43 | buy | ― | Upgraded | 08/25/26 | ||
| Kristen Kluska | Cantor Fitzgerald | EUR 3.14→EUR 25.11 | buy | ― | Upgraded | 08/14/26 | ||
| Jason McCarthy | Maxim Group | ― | hold | ― | Reiterated | 08/14/26 | ||
| Matthew Venezia | Alliance Global Partners | ― | hold | ― | Reiterated | 07/30/26 | ||
| Rick Bienkowski | Ladenburg Thalmann & Co. | ― | hold | ― | Downgraded | 07/30/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | 10/06/26 | ― | hold | ― | Reiterated | H.C. Wainwright | ||
| Boobalan Pachaiyappan | 10/06/26 | EUR 6.28 | hold | ― | Reiterated | Roth MKM | ||
| Catherine Novack | 09/27/26 | ― | hold | ― | Reiterated | JonesTrading | ||
| Madison Elsaadi | 09/14/26 | EUR 4.48→EUR 18.83 | buy | ― | Upgraded | B. Riley Securities | ||
| Edward Tenthoff | 09/01/26 | EUR 1.79→EUR 22.42 | buy | ― | Upgraded | Piper Sandler | ||
| Leland Gershell | 08/25/26 | EUR 48.43 | buy | ― | Upgraded | Oppenheimer | ||
| Kristen Kluska | 08/14/26 | EUR 3.14→EUR 25.11 | buy | ― | Upgraded | Cantor Fitzgerald | ||
| Jason McCarthy | 08/14/26 | ― | hold | ― | Reiterated | Maxim Group | ||
| Matthew Venezia | 07/30/26 | ― | hold | ― | Reiterated | Alliance Global Partners | ||
| Rick Bienkowski | 07/30/26 | ― | hold | ― | Downgraded | Ladenburg Thalmann & Co. |
Best Analysts Covering Capricor Therapeutics
Copying Kristen Kluska's trades and holding each position for 3 Months would result in 35.71% of your transactions generating a profit, with an average return of +19.57% per trade.
Copying Kristen Kluska's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +59.01% per trade.
Copying Kristen Kluska's trades and holding each position for 2 Years would result in 21.43% of your transactions generating a profit, with an average return of +29.16% per trade.
0HTB Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 12 | 15 | 7 | 7 | 4 |
| Buy | 4 | 4 | 1 | 1 | 0 |
| Hold | 0 | 10 | 17 | 18 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 29 | 25 | 26 | 14 |
In the current month, 0HTB has received 4 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. 0HTB average Analyst price target in the past 3 months is 24.21.
0HTB Financial Forecast
0HTB Earnings Forecast
Next quarter’s earnings estimate for 0HTB is -EUR 0.11 with a range of -EUR 0.66 to EUR 2.03. The previous quarter’s EPS was -EUR 0.63. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
0HTB Sales Forecast
Next quarter’s sales forecast for 0HTB is EUR 37.35M with a range of EUR 0 to EUR 179.08M. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
